Benefit of Self-monitoring of Anticoagulation Instrument

NACompletedINTERVENTIONAL
Enrollment

919

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Mechanical Prosthetic Heart Valve ImplantationPatient Self Monitoring of Oral Anticoagulent Therapy
Interventions
DEVICE

INRatio / Coaguchek XS

INR measured by patient himself using INRation or Coaguchek device. And one follow-up of INR per month, measured in laboratory.

DEVICE

Conventional follow-up of anti-coagulation

At least, one follow-up of INR per month. Measured in laboratory.

Trial Locations (1)

33604

Pôle Cardio-Thoracique - Hôpital Cardiologique du Haut-Lévêque - CHU de Bordeaux - Avenue de Magellan, Pessac

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Ministry of Health, France

OTHER_GOV

collaborator

Hoffmann-La Roche

INDUSTRY

collaborator

Biodis

UNKNOWN

lead

University Hospital, Bordeaux

OTHER